INTRAVENOUS IRON SUCROSE (VENOFER®) ALONE IS CAPABLE TO CORRECT ANAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON RENAL REPLACEMENT THERAPY

被引：0
|
作者：
Schaefer, Roland M. [1 ]
Khasabov, N. N. [2 ]
Ermolenko, V. M. [3 ]
Gurevich, K. Y. [4 ]
Schreiber, R. [5 ]
Shilo, V. Y. [6 ]
Tomilina, N. A. [7 ]
机构：
[1] Univ Munster, Munster, Germany
[2] Pirogov Med Ctr, Moscow, Russia
[3] Botkin Clin Hosp, Moscow, Russia
[4] Clin Extracorporeal Hemocorrect, St Petersburg, Russia
[5] Dialysis Ctr, Coesfeld, Germany
[6] City Hosp 20, Moscow, Russia
[7] City Hosp 52, Moscow, Russia
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A311 / A311
页数：1
相关论文
共 50 条
  • [41] THE IMPACT OF ANAEMIA AND INTRAVENOUS IRON REPLACEMENT THERAPY ON EXERCISE CAPACITY IN PATIENTS AFTER CARDIAC SURGERY
    Nugara, C.
    Vitale, G.
    Sarullo, S.
    Sarullo, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E61 - E61
  • [42] Iron replacement therapy in the management of anaemia in non-dialysis chronic renal failure patients: Perspective of the Spanish Nephrology Society Anaemia Group
    Cases, Aleix
    Jesus Puchades, Maria
    de Sequera, Patricia
    Quiroga, Borja
    Martin-Rodriguez, Leyre
    Gorriz, Jose Luis
    Portoles, Jose
    NEFROLOGIA, 2021, 41 (02): : 123 - 136
  • [43] Employment in the patient with chronic kidney disease related to renal replacement therapy
    Julian-Mauro, Juan C.
    Molinuevo-Tobalina, Jesus A.
    Sanchez-Gonzalez, Juan C.
    NEFROLOGIA, 2012, 32 (04): : 439 - 445
  • [44] Predictors of renal replacement therapy and mortality in children with chronic kidney disease
    Kari, Jameela A.
    El Desoky, Sherif M.
    Farag, Youssef M.
    Singh, Ajay K.
    SAUDI MEDICAL JOURNAL, 2015, 36 (01) : 32 - 39
  • [45] PREDICTORS OF RENAL REPLACEMENT THERAPY AND MORTALITY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
    Kari, Jameela
    El Desoky, Sherif
    Farag, Youssef Mk
    Singh, Ajay
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1610 - 1610
  • [46] Anaemia of chronic renal disease and pathogenesis and management, with reference to the use of erythropoietin and intravenous iron.
    Levin, NW
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 2122 - 2122
  • [47] Use of Procalcitonin in Patients With Various Degrees of Chronic Kidney Disease Including Renal Replacement Therapy
    Grace, Eddie
    Turner, R. Mackenzie
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1761 - 1767
  • [48] Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease
    Conway, Bryan
    Webster, Angela
    Ramsay, George
    Morgan, Neal
    Neary, John
    Whitworth, Caroline
    Harty, John
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) : 1930 - 1937
  • [49] Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
    Kotenko, Oleg N.
    Abolyan, Liubov, V
    Kuteinikov, Vladislav Iu.
    Vinogradov, Vladimir E.
    Fomin, Victor V.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (01) : 32 - 37
  • [50] COMPARISON OF INTRAVENOUS IRON SUCROSE VERSUS LOW-MOLECULAR-WEIGHT IRON DEXTRAN IN CHRONIC KIDNEY DISEASE
    Sinha, Smeeta
    Chiu, Diana Y. Y.
    Peebles, George
    Kolakkat, Shabeer
    Lamerton, Elizabeth
    Fenwick, Sean
    Kalra, Philip A.
    JOURNAL OF RENAL CARE, 2009, 35 (02) : 67 - 73
12345